GRANT OPPORTUNITIES from National Institutes of Health

21 March 2013

The purpose of this FOA for R01 applications is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, optimize combinations, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological treatment interventions. Research of interest includes but is not limited to Stage II and Stage III efficacy research.

for more details <<<CLICK HERE>>>